CLEC12A and acute myeloid leukemia: Tashiro et al. developed CLL-1-specific CAR-T cells (CLL-1.CAR-Ts) that showed targeted activity against CLL-1 + AML cell lines, patient samples, and AML xenografts in both in vitro and in vivo models.